Health
Sacubitril/Valsartan Treatment for HFpEF Shown to Reduce NT-proBNP Levels – AJMC.com Managed Markets Network
Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators…
Among several measures evaluated in a 24-week, randomized, double-blind, parallel group clinical trial comparing outcomes among patients with heart failure with preserved ejection fraction (HFpEF; left ventricular ejection fraction > 40%), sacubitril/valsartan…
Continue Reading
-
Noosa News24 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
Noosa News21 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General19 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Business24 hours agoEverything you need to know about the BHP dividend